|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 994 KRW | +8.52% |
|
-.--% | -80.70% |
| Mar. 29 | CANARIABIO Inc.(KOSDAQ:A016790) dropped from S&P Global BMI Index | CI |
| Jan. 24 | Quest PharmaTech Inc. Says Oregovomab Phase III Clinical Study Fails Futility Analysis | MT |
On November 17, 2022, CANARIABIO Inc. closed the transaction.
| 1st Jan change | Capi. | |
|---|---|---|
| -80.70% | 137M | |
| +15.92% | 11.94B | |
| +5.47% | 5.41B | |
| +4.59% | 4.59B | |
| -19.63% | 2.73B | |
| +3.25% | 1.92B | |
| -17.87% | 1.21B | |
| -18.21% | 948M | |
| -11.45% | 943M | |
| +3.02% | 847M |
CANARIABIO INC. 
